CD Formulation Diversifies Tablet Dosage Form Development Options
Tablets are often the first choice of solid dosage forms for many pharmaceutical companies. On November 16, 2021, the US-based contract service provider, CD Formulation announces that it has started to diversify its tablet dosage form development options and this attempt will be completed shortly.
Selecting the right dosage form is conducive to the success of marketing a new medicine. Tablets are becoming one of the most popular dosage forms as they have shown multiple advantages such as good physical and chemical stability, ease of transportation as well as good patient compliance.
Tablet manufacturing techniques have been evolving over the past decade. “To achieve the most desirable formulation performance for clients, our scientific team has started to use some of the most recent technologies. And untiring efforts will be continuously made so that the most suitable methods can be selected and utilized in each tailor-made contract research project,” says a senior scientist from CD Formulation.
The tablet dosage form development solutions provided by CD Formulation are widely ranged, covering conventional tablets, coated tablets, multilayer tablets, effervescent tablets, chewable tablets, dispersion tablets, sublingual tablets, buccal tablets, implanted tablets, solution tablets, and sustained release tablets.
Granulation and direct compression are necessary steps in the manufacturing of tablets. To ensure an even distribution of the active compound in the final tablet, ingredients must be granulated before compression if they cannot be well-mixed with the simple blending processes. There are wet granulation and dry granulation. Moreover, numerous modifications in tableting presses have also been made to enhance efficiency and productivity. Novel techniques based on laser, tomography, fluorescence, spectroscopy and acoustic approaches have been developed as well. All these advances help diversify strategies to develop robust tablet dosage forms with excellent performance attributes.
For more information about CD Formulation’s tablet dosage form development services, please visit https://www.formulationbio.com/tablets.html.
About CD Formulation
As a science-driven company, CD Formulation has accumulated rich experience in drug formulation and different dosage form development. It is now qualified to serve the pharmaceutical industry providing CRO services to develop, produce and design pharmaceutical excipients. With an innovative spirit and a down-to-earth attitude, the company is missioned to address the long-standing issue of new active pharmaceutical ingredient (API) development. It has completed several development projects and proudly extends its capability, which covers generic to innovative formulation with an ambition to enhance the solubility and bioavailability of difficult-to-formulate compounds.